Product Information
MIDODRINE HCL 2.5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0737 per EA under NDC 62332033831. Its NADAC has been published 271 times since Jul 28, 2021.
FDA first approved this application on Jan 21, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332033831
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIDODRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214734FDA Approved
1/21/2021
TE Code
AB
On Market Since
1/22/2021
Pharmacological Classes
Price Statistics
The NADAC for MIDODRINE HCL 2.5 MG TABLET has been published 271 times since Jul 28, 2021, and over the history we have for it it has declined 65.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0737 per EA |
|---|---|
| All-time high | $0.2450 (Dec 15, 2021) |
| All-time low | $0.0668 (Nov 20, 2024) |
| 52-week high | $0.0740 |
| 52-week low | $0.0703 |
| Median price | $0.1118 |
| Average price | $0.1339 |
| Largest weekly change | +59.2% (Nov 22, 2023) |
| Weeks tracked | 271 |
| Tracking since | Jul 28, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MIDODRINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MIDODRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIDODRINE HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 2.5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0737 per EA (NDC 62332033831), effective Sep 30, 2026.
How has the price of MIDODRINE HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIDODRINE HCL 2.5 MG TABLET has declined 65.5%. It has been tracked across 271 weekly CMS publications since Jul 28, 2021.
What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 2.5 MG TABLET?
Since Jul 28, 2021, the NADAC for MIDODRINE HCL 2.5 MG TABLET has ranged from a low of $0.0668 (Nov 20, 2024) to a high of $0.2450 (Dec 15, 2021), with a median of $0.1118 per EA.
Are there cheaper alternatives to MIDODRINE HCL 2.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MIDODRINE HCL 2.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MIDODRINE HCL 2.5 MG TABLET?
MIDODRINE HCL 2.5 MG TABLET (NDC 62332033831) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.